Financials
- Market Capitalization 1.76 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.3
市销率
162.41
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2066 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.02 USD | -8.44% | -27.06% | +1.88% | -5.10% | 1.82 B USD | ||
| 2069 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.04 USD | -4.49% | -4.94% | -1.94% | +113.76% | 1.80 B USD | ||
| 2093 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -7.30% | -16.46% | 0.00% | -37.85% | 1.75 B USD | ||
| 2112 | FTRE Fortrea Holdings Inc. - Common Stock | 17.86 USD | +0.56% | -0.78% | +6.88% | +250.88% | 1.69 B USD |